Display options
Cite
Sasirekha B, Usha MS, Amruta JA, et al. Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus. 3 Biotech. 2013;4(1):85-89doi: 10.1007/s13205-013-0133-5.
Sasirekha, B., Usha, M. S., Amruta, J. A., Ankit, S., Brinda, N., & Divya, R. (2014). Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus. 3 Biotech, 4(1), 85-89. https://doi.org/10.1007/s13205-013-0133-5
Sasirekha, B, et al. "Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus." 3 Biotech vol. 4,1 (2014): 85-89. doi: https://doi.org/10.1007/s13205-013-0133-5
Sasirekha B, Usha MS, Amruta JA, Ankit S, Brinda N, Divya R. Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus. 3 Biotech. 2014 Feb;4(1):85-89. doi: 10.1007/s13205-013-0133-5. Epub 2013 Apr 02. PMID: 28324465; PMCID: PMC3909568.
Copy Download .nbib Format: NLM
Share it on

3 Biotech. 2014 Feb;4(1):85-89. doi: 10.1007/s13205-013-0133-5. Epub 2013 Apr 02.

Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus.

3 Biotech

B Sasirekha, M S Usha, J A Amruta, S Ankit, N Brinda, R Divya

Affiliations

  1. Department of Microbiology, Center for Post Graduate Studies, Jain University, 18/3, 9th Main, Jayanagar 3rd Block, Bangalore, 560011, India. [email protected].
  2. Department of Microbiology, Center for Post Graduate Studies, Jain University, 18/3, 9th Main, Jayanagar 3rd Block, Bangalore, 560011, India.

PMID: 28324465 PMCID: PMC3909568 DOI: 10.1007/s13205-013-0133-5

Abstract

Clindamycin is one of the important alternative antibiotics in the therapy of Staphylococcus aureus infections. Clinical failure of clindamycin therapy has been reported due to multiple mechanisms that confer resistance to macrolides, lincosamides and Streptogramin B (MLS

Keywords: D test; Inducible MLSB phenotype; Inducible clindamycin; Staphylococcus aureus

References

  1. Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):376-8 - PubMed
  2. Ann Clin Microbiol Antimicrob. 2006 Sep 14;5:22 - PubMed
  3. J Clin Microbiol. 2003 Oct;41(10):4740-4 - PubMed
  4. J Clin Microbiol. 2004 Jun;42(6):2777-9 - PubMed
  5. Pediatr Infect Dis J. 2002 Jun;21(6):530-4 - PubMed
  6. Indian J Med Res. 1996 Apr;103:212-5 - PubMed
  7. Indian J Med Res. 2006 Apr;123(4):571-3 - PubMed
  8. J Clin Microbiol. 2005 Apr;43(4):1716-21 - PubMed
  9. Clin Infect Dis. 2003 Nov 1;37(9):1257-60 - PubMed
  10. J Postgrad Med. 2009 Jul-Sep;55(3):176-9 - PubMed
  11. Int J Antimicrob Agents. 2004 Nov;24(5):515-8 - PubMed
  12. Clin Infect Dis. 2001 May 15;32 Suppl 2:S114-32 - PubMed
  13. Antimicrob Agents Chemother. 2005 Mar;49(3):1222-4 - PubMed
  14. Euro Surveill. 2006 Jul;11(7):164-7 - PubMed
  15. J Med Microbiol. 2007 Mar;56(Pt 3):342-345 - PubMed
  16. Indian J Med Microbiol. 2010 Apr-Jun;28(2):124-6 - PubMed
  17. Pak J Biol Sci. 2007 Jan 1;10(1):189-92 - PubMed
  18. Mayo Clin Proc. 1999 Aug;74(8):825-33 - PubMed
  19. BMC Infect Dis. 2006 Jul 28;6:125 - PubMed
  20. Clin Microbiol Infect. 2006 Sep;12(9):844-52 - PubMed
  21. Clin Infect Dis. 2002 Feb 15;34(4):482-92 - PubMed
  22. Ann Clin Microbiol Antimicrob. 2006 Dec 02;5:30 - PubMed
  23. J Clin Microbiol. 2006 Nov;44(11):4072-6 - PubMed

Publication Types